2015, Volume 17, Issue 6
Strategic Study of CAE >> 2015, Volume 17, Issue 6
Effect of levonorgestrel intrauterine system on IGF-1 and the dependablity study of prevention pelvic inflammatory disease
Maternal and Children Health Hospital, Jiaxing, Zhejiang 314051, China
Next Previous
Abstract
Objective: To study the effect of levonorgestrel Intrauterine System on insulin-like growth factor-l (IGF-1) and the result of levonorgestrel Intrauterine System Prevention pelvic inflammatory disease. Methods: The 450 cases of hysteroscopic resection for endometrial polyps divided to study group(198 cases) who were placed levonorgestrel Intrauterine System in uterus after hysteroscopic electroresection, and control group(252 cases) who were not placted at random. The IGF-1 expression of endometrial biopsy specimens during intraoperative and rechected after 6 months were check out by immunohis to chemistry. Patients were followed up for 2Syears to analyse the effluence of pelvic inflammatory disease. Results: All patients had successful surgery. Intraoperative specimens compared with afteroperation specimens of the IGF-1 expression, there was a significant differencesSin study group but control group. Followed up for 2 years, 14 cases has pelvic inflammatory disease in study group,39 cases has pelvic inflammatory disease in control group,there was a significant differences. The thickness of endometrium after operation is lower than before operation in study group but control group. Conclusions:It may be the mainSmechanism of Prevention pelvic inflammatory disease and inhibition endometrium that Levonorgestrel intrauterine system can prevent endometrial IGF-1 expression.
Keywords
levonorgestrel ; Intrauterine system insulin-like growth factor-1 ; pelvic inflammatory disease
References
[ 1 ] 史华平，周良燕. 三联疗法治疗慢性盆腔炎的疗效观察[J]. 中国 基层医药，2013，20（12）：18-54． link1
[ 2 ] Bragheto A M，Caserta N，Bahamondes L，et al. Effectiveness of the levonorgestrel- releasing intrauterine system in the the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging[J]. Contraception，2007，76（3）：195-199． link1
[ 3 ] ESHRE Capri Workshop Group. Intrauterine devices intrauterine systems[J]. Hum Reprod Update，2008，14（3）：197-208. link1
[ 4 ] Sheng J，Zhang W Y，Zhang J P，et al. The LNG-IUS study on adenomyosis：A 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrheal associated with adenomyosis[J]. Contraception，2009，79（3）：189-193. link1
[ 5 ] 聂 莉，谢梅青，王良岸. 左炔诺孕酮宫内缓释系统对增生过长 子宫内膜IGF-I和IGF-II及其相应受体表达的影响[J].实用诊 断与治疗杂志，2006，20（8）：550-552. link1
[ 6 ] 张玉华，丛明燕. 曼月乐治疗功能失调性子宫出血的临床观 察[J]. 华北煤炭医学院学报，2008，10（4）：515-516. link1
[ 7 ] 吕映频，祁秀娟，段玉英，等. 左炔诺孕酮宫内缓释系统治疗功 能失调性子宫出血的临床观察[J]. 现代妇产科进展，2006，15 （l0）：753-756. link1
[ 8 ] 翁卓娅，朱旭霞. 左炔诺孕酮宫内缓释系统治疗月经过多的临 床观察[J]. 中国妇幼保健，2007，22：4816-4817. link1
[ 9 ] 聂 莉，谢梅青，王良岸. 左炔诺孕酮宫内缓释系统对增生过长 子宫内膜形态计量学的影响[J]. 临床医学，2006，26（9）： 74-75. link1
京公网安备 11010502051620号
